Pathstone Family Office’s Zimmer Biomet ZBH Stock Holding History

Pathstone Family Office’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.8M	Buy	15,955 +10,413	+188%	+$1.32M	0.01%	495
2023 Q2	$864K	Buy	5,542 +121	+2%	+$16.4K	0.01%	532
2023 Q1	$681K	Sell	5,421 -10,175	-65%	-$1.28M	0.01%	568
2022 Q4	$5.04M	Buy	15,596 +2,870	+23%	+$333K	0.04%	279
2022 Q3	$1.34M	Buy	12,726 +8,170	+179%	+$897K	0.01%	604
2022 Q2	$479K	Buy	4,556 +1,636	+56%	+$194K	0.01%	592
2022 Q1	$380K	Sell	2,920 -253	-8%	-$30.5K	0.01%	657
2021 Q4	$391K	Buy	3,173 +1,394	+78%	+$182K	0.01%	630
2021 Q3	$254K	Hold	1,779	–	–	0.01%	728
2021 Q2	$278K	Buy	+1,779	New	+$288K	0.01%	671
2021 Q1	–	Sell	-310	Closed	-$46K	–	1368
2020 Q4	$46K	Buy	310 +114	+58%	+$16.1K	﹤0.01%	531
2020 Q3	$26K	Hold	196	–	–	﹤0.01%	445
2020 Q2	$23K	Hold	196	–	–	﹤0.01%	409
2020 Q1	$19K	Hold	196	–	–	﹤0.01%	424
2019 Q4	$284K	Sell	196 -134	-41%	-$18.5K	﹤0.01%	365
2019 Q3	$43K	Buy	+330	New	+$42.6K	0.01%	295
2019 Q2	–	Sell	-196	Closed	-$24K	–	923
2019 Q1	$24K	Buy	+196	New	+$22.3K	﹤0.01%	417
2018 Q2	–	Sell	-184	Closed	-$20K	–	345
2018 Q1	$20K	Buy	+184	New	+$21.4K	0.01%	161
2017 Q2	–	Sell	-7	Closed	-$1K	–	660
2017 Q1	$1K	Buy	+7	New	+$793	﹤0.01%	537

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pathstone Family Office's ZBH Position: Q3 2023 in Review

Pathstone Family Office increased its Zimmer Biomet (ZBH) stake by 188% in Q3 2023, buying an estimated $1.32M and bringing the position to 15,955 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #495.

Pathstone Family Office first reported a position in ZBH in Q1 2017 and has held it in 19 quarters since. The position peaked at $5.04M in Q4 2022. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Pathstone Family Office held 15,955 shares of Zimmer Biomet worth $1.8M as of Q3 2023.
Pathstone Family Office bought 10,413 Zimmer Biomet shares in Q3 2023, an estimated $1.32M.
Zimmer Biomet made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #495 holding.
Pathstone Family Office first reported a position in Zimmer Biomet in Q1 2017 and has held it in 19 quarters since.
Pathstone Family Office's Zimmer Biomet position peaked at $5.04M in Q4 2022.
1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.